Figure A2.3. Basic structure of the cost-effectiveness model.

Figure A2.3Basic structure of the cost-effectiveness model

The same structure was applied to all ten treatment sequences in the analysis.

From: Appendix 2, Mixed treatment comparison and cost-effectiveness analysis for sequences of oxaliplatin and irinotecan-based chemotherapy in the treatment of advanced and metastatic colorectal cancer

Cover of Colorectal Cancer
Colorectal Cancer: The Diagnosis and Management of Colorectal Cancer.
NICE Clinical Guidelines, No. 131.
National Collaborating Centre for Cancer (UK).
Copyright © 2011, National Collaborating Centre for Cancer.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.